The Cannabis Science is a company that is focused on the healing power of cannabis and has introduced a groundbreaking cannabis patch that can effectively treat fibromyalgia symptoms and diabetic nerve pain.

These patches relieve neurological nerve pain by releasing controlled doses of cannabis into the skin and is eventually absorbed into the bloodstream. Experts from Cannabis Science say that controlled doses of cannabis will not harm the body, nor does it have any negative side effects.

There are two ways for patients to take the treatment — insertion into a penetrable membrane that allows full absorption, or thin layers that melt on the skin. The thin layers are packed with powerful cannabinoid extract that effectively relieves pain once it reaches the central nervous system.

Mr. Raymond C. Dabney, CEO of Cannabis Science says that their product is just one small aspect of Cannabis Science’s abilities.

“The development of these two new pharmaceutical medicinal applications are just the tip of the iceberg for what we see as the future for Cannabis Science. While we strive to increase our land capacity for growth and facilities to produce our own product to supply our scientists with proprietary materials to make these formulations, we are also busy researching more potential needs for Cannabis related medical applications and developing the methods for delivery of these medications,” the CEO said.

It is said that over 10% of Americans have Fibromyalgia and a lot of them don’t even know it. The few who are attended to are pain medications and opium to avoid anxiety and depression. All of which are common symptoms of the disease.

Neuropathic pain is a pain state that is often accompanied by injured nerve endings and tissue. It can be treated with acupuncture, stimulation of morphine.

Since cannabis patches have been proven to treat pain linked to Diabetic Nerve Pain and Fibromyalgia, it’s only logical to see these patches as a treatment for other forms pain management as the future draws near.

Dabney does say that his organization is just getting on board. ”As more states nationwide legislate for the legalization of cannabis and cannabis-derived medications, we here at Cannabis Science are focused on developing pharmaceutical formulations and applications to supply the huge growing demand expected over the coming few years.\